NDC 72266-199

NDC codes

FDA NDC Directory

Product NDC (as listed)72266-199Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72266-0199Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72266-199-01	72266019901	1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLEMarketed from Sep 26, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Timolol Maleate Ophthalmic Gel Forming Solution
Generic name (nonproprietary): timolol maleate ophthalmic gel forming solution
Active ingredients: Timolol maleate — 2.5 mg/mL
Dosage form: Solution, Gel forming / drops
Route: Ophthalmic
Labeler: FOSUN PHARMA USA INC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214645
Marketing start: Jun 24, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 72266-199_3a229bef-de33-9ec4-e063-6394a90ad1b7SPL ID 3a229bef-de33-9ec4-e063-6394a90ad1b7SPL set ID e93036c6-3120-e989-e053-2a95a90acf7fRxCUI 313407, 313408UNII P8Y54F701RUPC 0372266199010
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472266019901 followed by a unit qualifier and the quantity

Package 72266-0199-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 17, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Timolol maleate sterile ophthalmic gel forming solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214645

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214645
Product	Strength	Form · route	Labeler	Product NDC
Timolol Maleate Ophthalmic Gel Forming Solution	Timolol maleate 5 mg/mL	Solution, Gel forming / dropsOphthalmic	FOSUN PHARMA USA INC	72266-200
timolol maleate ophthalmic gel forming solution	Timolol maleate 2.5 mg/mL	Solution, Gel forming / dropsOphthalmic	Gland Pharma Limited	68083-457
timolol maleate ophthalmic gel forming solutiontimolol maleate ophthalmic gel forming	Timolol maleate 5 mg/mL	Solution, Gel forming / dropsOphthalmic	Gland Pharma Limited	68083-458
Timolol Maleate	Timolol maleate 2.5 mg/mL	Solution, Gel forming / dropsOphthalmic	Sagent Pharmaceuticals	25021-008
Timolol Maleate	Timolol maleate 5 mg/mL	Solution, Gel forming / dropsOphthalmic	Sagent Pharmaceuticals	25021-009

Timolol Maleate Ophthalmic Gel Forming Solution NDC 72266-199